IMMUTEP director reports 4.05M shares, performance rights
IMMUTEP Ltd director Pete A. Meyers filed an initial ownership report showing both ordinary shares and performance rights.
Rhea-AI Filing Summary
IMMUTEP Ltd director Pete A. Meyers filed an initial ownership report showing both ordinary shares and performance rights. He holds 4,052,173 Ordinary Shares directly. In addition, he holds performance rights over blocks of 388,889, 758,631, 650,000, and 650,000 underlying Ordinary Shares at an exercise price of $0.0000 per share.
The footnotes state these performance rights were granted on December 16, 2022 and December 2, 2025. Vesting dates run from October 1, 2026 through December 1, 2029, and each grant is dependent on Mr. Meyers meeting specified vesting conditions, with expiration dates extending to December 2, 2030.
Positive
- None.
Negative
- None.
Insider Trade Summary
5 transactions reported
Mixed
5 txns
Insider
Meyers Pete A.
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Performance rights (right to receive) | -- | -- | -- |
| holding | Performance rights (right to receive) | -- | -- | -- |
| holding | Performance rights (right to receive) | -- | -- | -- |
| holding | Performance rights (right to receive) | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
Holdings After Transaction:
Performance rights (right to receive) — 2,447,520 contracts (Direct);
Ordinary Shares — 4,052,173 shares (Direct)
Footnotes (4)
- F1. Granted on December 16, 2022. 388,889 performance rights will vest on October 1, 2026 is dependent on Mr. Meyers meeting the vesting conditions.
- F2. Granted on December 2, 2025. 758,631 performance rights will vest on December 1,2027 and the vesting of the remaining 1,300,000 performance rights is dependent on Mr. Meyers meeting the vesting conditions.
- F3. Granted on December 2, 2025. 650,000 performance rights will vest on December 1,2028 and the vesting of the remaining 650,000 performance rights is dependent on Mr. Meyers meeting the vesting conditions.
- F4. Granted on December 2, 2025. 650,000 performance rights will vest on December 1,2029 and the vesting of the performance rights is dependent on Mr. Meyers meeting the vesting conditions.
Key Figures
Direct Ordinary Shares: 4,052,173 shares
Performance rights block 1: 388,889 underlying shares
Performance rights block 2: 758,631 underlying shares
+4 more
7 metrics
Direct Ordinary Shares
4,052,173 shares
Total Ordinary Shares held directly following transactions
Performance rights block 1
388,889 underlying shares
Granted December 16, 2022; vesting October 1, 2026; expiration December 16, 2027
Performance rights block 2
758,631 underlying shares
Granted December 2, 2025; vesting December 1, 2027; expiration December 2, 2030
Performance rights block 3
650,000 underlying shares
Granted December 2, 2025; vesting December 1, 2028; expiration December 2, 2030
Performance rights block 4
650,000 underlying shares
Granted December 2, 2025; vesting December 1, 2029; expiration December 2, 2030
Exercise price
$0.0000 per share
Exercise price for reported performance rights over Ordinary Shares
Unknown transaction entries
5 entries
Form 3 transactionSummary shows 5 holding/unknown-code entries
Key Terms
Performance rights, vesting conditions, Ordinary Shares, exercise price
4 terms
Performance rights financial
"Performance rights (right to receive)"
Performance rights are conditional awards that give employees or executives the promise of receiving company shares or cash only if the business meets specific targets or survives for a set period. They work like a bonus you only get when certain goals are hit, so they matter to investors because they can increase the number of shares outstanding (dilution), signal management’s incentives and confidence in future results, and affect per-share earnings and valuation.
vesting conditions financial
"vesting of the performance rights is dependent on Mr. Meyers meeting the vesting conditions"
Vesting conditions are the rules that determine when someone earning company stock or stock options actually gains the right to keep or sell them, typically based on staying with the company for a set time or meeting performance targets. Think of it like keys that unlock gradually — some unlock by calendar date, others only after agreed milestones. Investors care because vesting shapes management incentives, the timing of share sales, and the number of shares that can enter the market, which can affect a company's valuation and ownership mix.
exercise price financial
"conversion_or_exercise_price": "0.0000""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
FAQ
What does the IMMUTEP (IMMP) Form 3 filing by Pete A. Meyers show?
The Form 3 shows director Pete A. Meyers reporting his initial holdings in IMMUTEP, including 4,052,173 Ordinary Shares and several blocks of performance rights over additional Ordinary Shares, all detailed with vesting and expiration dates.
When do Pete A. Meyers’s IMMUTEP (IMMP) performance rights vest?
Footnotes state that 388,889 performance rights vest on October 1, 2026, while other performance rights vest on December 1, 2027, December 1, 2028, and December 1, 2029, each subject to Mr. Meyers meeting specified vesting conditions.
What are the expiration dates of the IMMUTEP (IMMP) performance rights held by Pete A. Meyers?
The performance rights have expiration dates running through December 16, 2027 and December 2, 2030, depending on the specific grant. If vesting conditions are not met or rights are not exercised before expiry, they would lapse according to their stated expiration dates.
At what price can Pete A. Meyers exercise his IMMUTEP (IMMP) performance rights?
The filing shows an exercise price of $0.0000 per share for all reported performance rights. This means that, upon meeting vesting conditions, the underlying Ordinary Shares can be received without additional cash payment under the terms disclosed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
